Selected research
Market Analysis & Forecast
Global Custom Assay Development Market Analysis and Forecast 2026-2032
Market perspective
The global Custom Assay Development market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Custom Assay Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Custom Assay Development include 2BScientific, PerkinElmer, Eurofins Discovery, Thermo Fisher Scientific, Creative Biolabs, PlexBio, Gyros Protein Technologies, Mission Bio and Sygnature Discovery, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Custom Assay Development, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Custom Assay Development, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Assay Development, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom Assay Development revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Assay Development market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Assay Development revenue, projected growth trends, production technology, application and end-user industry.
Custom Assay Development Segment by Company
2BScientific
PerkinElmer
Eurofins Discovery
Thermo Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate
Charles River Laboratories
Promega Corporation
ProteoGenix
R&D Systems
Luminex
Eremid Genomic Services
INDIGO Biosciences
Cellomatics Biosciences
Camtech
SynVivo
Custom Assay Development Segment by Type
Assay Development
Assay Optimization
Assay Conversion
New Analyte Development
Custom Coupling
Custom Conjugation
Sample Testing
Other
Custom Assay Development Segment by Application
Medicine
Biology
Environment
Academic
Others
Custom Assay Development Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Custom Assay Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Custom Assay Development company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Assay Development revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Assay Development
- Assay Optimization
- Assay Conversion
- New Analyte Development
- Custom Coupling
- Custom Conjugation
- Sample Testing
- Other
Applications
- Medicine
- Biology
- Environment
- Academic
- Others
Companies covered
- 2BScientific
- PerkinElmer
- Eurofins Discovery
- Thermo Fisher Scientific
- Creative Biolabs
- PlexBio
- Gyros Protein Technologies
- Mission Bio
- Sygnature Discovery
- AssayGate
- Charles River Laboratories
- Promega Corporation
- ProteoGenix
- R&D Systems
- Luminex
- Eremid Genomic Services
- INDIGO Biosciences
- Cellomatics Biosciences
- Camtech
- SynVivo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Custom Assay Development Market by Type
- 1.2.1 Global Custom Assay Development Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Assay Development
- 1.2.3 Assay Optimization
- 1.2.4 Assay Conversion
- 1.2.5 New Analyte Development
- 1.2.6 Custom Coupling
- 1.2.7 Custom Conjugation
- 1.2.8 Sample Testing
- 1.2.9 Other
- 1.3 Custom Assay Development Market by Application
- 1.3.1 Global Custom Assay Development Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medicine
- 1.3.3 Biology
- 1.3.4 Environment
- 1.3.5 Academic
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Assay Development Market Dynamics
- 2.1 Custom Assay Development Industry Trends
- 2.2 Custom Assay Development Industry Drivers
- 2.3 Custom Assay Development Industry Opportunities and Challenges
- 2.4 Custom Assay Development Industry Restraints
3 Global Growth Perspective
- 3.1 Global Custom Assay Development Market Perspective (2021-2032)
- 3.2 Global Custom Assay Development Growth Trends by Region
- 3.2.1 Global Custom Assay Development Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Custom Assay Development Market Size by Region (2021-2026)
- 3.2.3 Global Custom Assay Development Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Custom Assay Development Revenue by Players
- 4.1.1 Global Custom Assay Development Revenue by Players (2021-2026)
- 4.1.2 Global Custom Assay Development Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Custom Assay Development Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Custom Assay Development Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Custom Assay Development Key Players Headquarters & Area Served
- 4.4 Global Custom Assay Development Players, Product Type & Application
- 4.5 Global Custom Assay Development Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Custom Assay Development Market CR5 and HHI
- 4.6.3 2025 Custom Assay Development Tier 1, Tier 2, and Tier 3
5 Custom Assay Development Market Size by Type
- 5.1 Global Custom Assay Development Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Custom Assay Development Revenue by Type (2021-2032)
- 5.3 Global Custom Assay Development Revenue Market Share by Type (2021-2032)
6 Custom Assay Development Market Size by Application
- 6.1 Global Custom Assay Development Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Custom Assay Development Revenue by Application (2021-2032)
- 6.3 Global Custom Assay Development Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 2BScientific
- 7.1.1 2BScientific Company Information
- 7.1.2 2BScientific Business Overview
- 7.1.3 2BScientific Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.1.4 2BScientific Custom Assay Development Product Portfolio
- 7.1.5 2BScientific Recent Developments
- 7.2 PerkinElmer
- 7.2.1 PerkinElmer Company Information
- 7.2.2 PerkinElmer Business Overview
- 7.2.3 PerkinElmer Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.2.4 PerkinElmer Custom Assay Development Product Portfolio
- 7.2.5 PerkinElmer Recent Developments
- 7.3 Eurofins Discovery
- 7.3.1 Eurofins Discovery Company Information
- 7.3.2 Eurofins Discovery Business Overview
- 7.3.3 Eurofins Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.3.4 Eurofins Discovery Custom Assay Development Product Portfolio
- 7.3.5 Eurofins Discovery Recent Developments
- 7.4 Thermo Fisher Scientific
- 7.4.1 Thermo Fisher Scientific Company Information
- 7.4.2 Thermo Fisher Scientific Business Overview
- 7.4.3 Thermo Fisher Scientific Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.4.4 Thermo Fisher Scientific Custom Assay Development Product Portfolio
- 7.4.5 Thermo Fisher Scientific Recent Developments
- 7.5 Creative Biolabs
- 7.5.1 Creative Biolabs Company Information
- 7.5.2 Creative Biolabs Business Overview
- 7.5.3 Creative Biolabs Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.5.4 Creative Biolabs Custom Assay Development Product Portfolio
- 7.5.5 Creative Biolabs Recent Developments
- 7.6 PlexBio
- 7.6.1 PlexBio Company Information
- 7.6.2 PlexBio Business Overview
- 7.6.3 PlexBio Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.6.4 PlexBio Custom Assay Development Product Portfolio
- 7.6.5 PlexBio Recent Developments
- 7.7 Gyros Protein Technologies
- 7.7.1 Gyros Protein Technologies Company Information
- 7.7.2 Gyros Protein Technologies Business Overview
- 7.7.3 Gyros Protein Technologies Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.7.4 Gyros Protein Technologies Custom Assay Development Product Portfolio
- 7.7.5 Gyros Protein Technologies Recent Developments
- 7.8 Mission Bio
- 7.8.1 Mission Bio Company Information
- 7.8.2 Mission Bio Business Overview
- 7.8.3 Mission Bio Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.8.4 Mission Bio Custom Assay Development Product Portfolio
- 7.8.5 Mission Bio Recent Developments
- 7.9 Sygnature Discovery
- 7.9.1 Sygnature Discovery Company Information
- 7.9.2 Sygnature Discovery Business Overview
- 7.9.3 Sygnature Discovery Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.9.4 Sygnature Discovery Custom Assay Development Product Portfolio
- 7.9.5 Sygnature Discovery Recent Developments
- 7.10 AssayGate
- 7.10.1 AssayGate Company Information
- 7.10.2 AssayGate Business Overview
- 7.10.3 AssayGate Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.10.4 AssayGate Custom Assay Development Product Portfolio
- 7.10.5 AssayGate Recent Developments
- 7.11 Charles River Laboratories
- 7.11.1 Charles River Laboratories Company Information
- 7.11.2 Charles River Laboratories Business Overview
- 7.11.3 Charles River Laboratories Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.11.4 Charles River Laboratories Custom Assay Development Product Portfolio
- 7.11.5 Charles River Laboratories Recent Developments
- 7.12 Promega Corporation
- 7.12.1 Promega Corporation Company Information
- 7.12.2 Promega Corporation Business Overview
- 7.12.3 Promega Corporation Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.12.4 Promega Corporation Custom Assay Development Product Portfolio
- 7.12.5 Promega Corporation Recent Developments
- 7.13 ProteoGenix
- 7.13.1 ProteoGenix Company Information
- 7.13.2 ProteoGenix Business Overview
- 7.13.3 ProteoGenix Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.13.4 ProteoGenix Custom Assay Development Product Portfolio
- 7.13.5 ProteoGenix Recent Developments
- 7.14 R&D Systems
- 7.14.1 R&D Systems Company Information
- 7.14.2 R&D Systems Business Overview
- 7.14.3 R&D Systems Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.14.4 R&D Systems Custom Assay Development Product Portfolio
- 7.14.5 R&D Systems Recent Developments
- 7.15 Luminex
- 7.15.1 Luminex Company Information
- 7.15.2 Luminex Business Overview
- 7.15.3 Luminex Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.15.4 Luminex Custom Assay Development Product Portfolio
- 7.15.5 Luminex Recent Developments
- 7.16 Eremid Genomic Services
- 7.16.1 Eremid Genomic Services Company Information
- 7.16.2 Eremid Genomic Services Business Overview
- 7.16.3 Eremid Genomic Services Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.16.4 Eremid Genomic Services Custom Assay Development Product Portfolio
- 7.16.5 Eremid Genomic Services Recent Developments
- 7.17 INDIGO Biosciences
- 7.17.1 INDIGO Biosciences Company Information
- 7.17.2 INDIGO Biosciences Business Overview
- 7.17.3 INDIGO Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.17.4 INDIGO Biosciences Custom Assay Development Product Portfolio
- 7.17.5 INDIGO Biosciences Recent Developments
- 7.18 Cellomatics Biosciences
- 7.18.1 Cellomatics Biosciences Company Information
- 7.18.2 Cellomatics Biosciences Business Overview
- 7.18.3 Cellomatics Biosciences Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.18.4 Cellomatics Biosciences Custom Assay Development Product Portfolio
- 7.18.5 Cellomatics Biosciences Recent Developments
- 7.19 Camtech
- 7.19.1 Camtech Company Information
- 7.19.2 Camtech Business Overview
- 7.19.3 Camtech Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.19.4 Camtech Custom Assay Development Product Portfolio
- 7.19.5 Camtech Recent Developments
- 7.20 SynVivo
- 7.20.1 SynVivo Company Information
- 7.20.2 SynVivo Business Overview
- 7.20.3 SynVivo Custom Assay Development Revenue and Gross Margin (2021-2026)
- 7.20.4 SynVivo Custom Assay Development Product Portfolio
- 7.20.5 SynVivo Recent Developments
8 North America
- 8.1 North America Custom Assay Development Revenue (2021-2032)
- 8.2 North America Custom Assay Development Revenue by Type (2021-2032)
- 8.2.1 North America Custom Assay Development Revenue by Type (2021-2026)
- 8.2.2 North America Custom Assay Development Revenue by Type (2027-2032)
- 8.3 North America Custom Assay Development Revenue Share by Type (2021-2032)
- 8.4 North America Custom Assay Development Revenue by Application (2021-2032)
- 8.4.1 North America Custom Assay Development Revenue by Application (2021-2026)
- 8.4.2 North America Custom Assay Development Revenue by Application (2027-2032)
- 8.5 North America Custom Assay Development Revenue Share by Application (2021-2032)
- 8.6 North America Custom Assay Development Revenue by Country
- 8.6.1 North America Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Custom Assay Development Revenue by Country (2021-2026)
- 8.6.3 North America Custom Assay Development Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Custom Assay Development Revenue (2021-2032)
- 9.2 Europe Custom Assay Development Revenue by Type (2021-2032)
- 9.2.1 Europe Custom Assay Development Revenue by Type (2021-2026)
- 9.2.2 Europe Custom Assay Development Revenue by Type (2027-2032)
- 9.3 Europe Custom Assay Development Revenue Share by Type (2021-2032)
- 9.4 Europe Custom Assay Development Revenue by Application (2021-2032)
- 9.4.1 Europe Custom Assay Development Revenue by Application (2021-2026)
- 9.4.2 Europe Custom Assay Development Revenue by Application (2027-2032)
- 9.5 Europe Custom Assay Development Revenue Share by Application (2021-2032)
- 9.6 Europe Custom Assay Development Revenue by Country
- 9.6.1 Europe Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Custom Assay Development Revenue by Country (2021-2026)
- 9.6.3 Europe Custom Assay Development Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Custom Assay Development Revenue (2021-2032)
- 10.2 China Custom Assay Development Revenue by Type (2021-2032)
- 10.2.1 China Custom Assay Development Revenue by Type (2021-2026)
- 10.2.2 China Custom Assay Development Revenue by Type (2027-2032)
- 10.3 China Custom Assay Development Revenue Share by Type (2021-2032)
- 10.4 China Custom Assay Development Revenue by Application (2021-2032)
- 10.4.1 China Custom Assay Development Revenue by Application (2021-2026)
- 10.4.2 China Custom Assay Development Revenue by Application (2027-2032)
- 10.5 China Custom Assay Development Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Custom Assay Development Revenue (2021-2032)
- 11.2 Asia Custom Assay Development Revenue by Type (2021-2032)
- 11.2.1 Asia Custom Assay Development Revenue by Type (2021-2026)
- 11.2.2 Asia Custom Assay Development Revenue by Type (2027-2032)
- 11.3 Asia Custom Assay Development Revenue Share by Type (2021-2032)
- 11.4 Asia Custom Assay Development Revenue by Application (2021-2032)
- 11.4.1 Asia Custom Assay Development Revenue by Application (2021-2026)
- 11.4.2 Asia Custom Assay Development Revenue by Application (2027-2032)
- 11.5 Asia Custom Assay Development Revenue Share by Application (2021-2032)
- 11.6 Asia Custom Assay Development Revenue by Country
- 11.6.1 Asia Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Custom Assay Development Revenue by Country (2021-2026)
- 11.6.3 Asia Custom Assay Development Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Custom Assay Development Revenue (2021-2032)
- 12.2 SAMEA Custom Assay Development Revenue by Type (2021-2032)
- 12.2.1 SAMEA Custom Assay Development Revenue by Type (2021-2026)
- 12.2.2 SAMEA Custom Assay Development Revenue by Type (2027-2032)
- 12.3 SAMEA Custom Assay Development Revenue Share by Type (2021-2032)
- 12.4 SAMEA Custom Assay Development Revenue by Application (2021-2032)
- 12.4.1 SAMEA Custom Assay Development Revenue by Application (2021-2026)
- 12.4.2 SAMEA Custom Assay Development Revenue by Application (2027-2032)
- 12.5 SAMEA Custom Assay Development Revenue Share by Application (2021-2032)
- 12.6 SAMEA Custom Assay Development Revenue by Country
- 12.6.1 SAMEA Custom Assay Development Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Custom Assay Development Revenue by Country (2021-2026)
- 12.6.3 SAMEA Custom Assay Development Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst